Estrogenicity of bisphenol A in a human endometrial carcinoma cell line

Molecular and Cellular Endocrinology

Volumn 150, Issue 1-2, 1999, Pages 179-187

  Bergeron, Renée M ^b   Thompson, Tommy B ^a   Leonard, Linda S ^a   Pluta, Linda ^a   Gaido, Kevin W ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b EXXONMOBIL UPSTREAM RESEARCH COMPANY   (United States)

Author keywords

Bisphenol A; ECC 1 cells; Estrogen; Estrogen receptor; Progesterone receptor; RT PCR

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING;

BINDING, COMPETITIVE; CARCINOMA; CELL DIVISION; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; PHENOLS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033602673     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00202-0     Document Type: Article

References (49)

1. CO and MCF-7 breast cancer cells. Mol. Endocrinol. 3:1989;22-28.
2. Bhattacharyya N., Ramsammy R., Eatman E., Hollis V., Anderson W. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen. J. Submicrosc. Cytol. Pathol. 26:1994;147-162.
3. Boettger-Tong H., Murthy L., Stancel G. Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol. Reprod. 53:1995;1398-1406.
4. Brenner R., West N. Hormonal regulation of the reproductive tract in female animals. Ann. Rev., Physiol. 37:1975;273-402.
5. Brotons J., Olea-Serrano M., Villalobos M., Pedraza V., Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ. Health Perspect. 103:1995;608-612.
6. Chirgwin J., Przybyla A., MacDonald R., Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribohuclease. Biochemistry. 18:1979;5294-5299.
7. Cicatiello L., Sica V., Bresciani F., Weisz A. Identification of a specific pattern of `immediate-early' gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor. 3:1993;17-30.
8. Cohen D., Curran T. The structure and function of the fos proto-oncogene. Oncogenesis. 1:1993;65-88.
9. DiAugustine R., Petruez P., Bell G., Brown C., Korach K., McLachlan J. et al. Influence of estrogen on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology. 122:1988;2355-2363.
10. Finch C., Felicio L., Mobbs C., Nelson J. varian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr. Rev. 5:1984;467-497.
11. Gaido K., Leonard L., Lovell S., Gould J., Babai D., Portier C., McDonnell D. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:1997;205-212.
12. Gill W., Schumacher G., Bibbo M. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J. Urol. 117:1977;477-480.
13. Gould, J., Leonard, L., Maness, S., Wagner, B., Conner, K., Zacharewski, et al. (1998). Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrin. 142, 203-214.
14. Hardin B., Bond G., Sikov M., Andrew F., Beliles R., Niemeier R. Testing of selected workplace chemicals for teratogenic potential. Scand. J. Work Environ. Health. 7:1981;66-75.
15. Herbst A., Paskanzer D., Robboy S., Friedlander L., Re S. Prenatal exposure to diethylstilbestrol: a propective comparison of exposed female offspring with unexposed controls. N. Engl. J. Med. 292:1975;334-339.
16. Hung Y.-C., Satyaswaroop P.G., Tabibzadeh S. The female reproductive system: cell lines from tumors of the human ovary and uterus. Hay R.J., Park J.-G., Gazdar A. Atlas of Human Tumor Cell Lines. 1994;359-386 Academic Press, San Diego.
17. Ignar-Trowbridge D., Teng C., Ross K., Parker M., Korach K., McLachlan J. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7:1993;992-998.
18. Ignar-Trowbridge D., Pimentel M., Parker M., McLachlan J., Korach K. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology. 137:1996;1735-1744.
19. Jobling S., Reynolds T., White R., Parker M.G., Sumpter J.P. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ. Health Perspect. 103:1995;582-587.
20. Jordan V., Fritz N., Tormey D. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration of node-positive patients with breast cancer. Cancer Res. 47:1987;624-630.
21. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H. et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1990;1603-1614.
22. Katzenellenbogen B. Dynamics of steroid hormone receptor action. Annu. Rev. Physiol. 42:1980;17-35.
23. Kirkland J., Murthy L., Stancel G. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol. Pharmacol. 43:1993;709-714.
24. Krishnan A., Stathis P., Permuth S., Tokes L., Feldman D. Bisphenol A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology. 132:1993;2279-2286.
25. Kuiper G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S. et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
26. Lessey B., Wahawisan R., Gorell T. Hormonal regulation of cytoplasmic estrogen and progesterone receptors in the beagle uterus and oviduct. Mol. Cell. Endocrinol. 21:1981;171-180.
27. Liaw J., Gould J., Welsch F. Gestational and early lactational influence of bisphenol A on the differentiation of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in rat brains. Fund. Appl. Toxicol. Suppl. 36:1997;14.
28. MacNamara P., O'Shaughnessy C., Manduca P., Loughrey H. Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures. Calcif. Tissue Int. 57:1995;436-441.
29. McDonnell D., Clemm D., Hermann T., Goldman M., Pike J. Analysis of estrogen receptor function in vitroreveals three distinct classes of antiestrogens. Mol. Endocrinol. 9:1995;659-669.
30. McLachlan, J., Newbold, R., Bullock, B. (1980). Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 40, 3988-3999.
31. Mukku V., Stancel G. Receptors for epidermal growth factor in the rat uterus. Endocrinology. 117:1985;149-154.
32. Muller R., Bravo R., Burckhardt J., Curran T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature. 312:1984;716-720.
33. Olea N., Pulgar R., Perez P., Olea-Serrano F., Rivas A., Novillo-Fertrell A. et al. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 104:1996;298-305.
34. Olea-Serrano N., Devleeschouwer N., Leclercq G., Heuson J. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur. J. Cancer Clin. Oncol. 21:1985;965-973.
35. Otto A., Faderl M., Schonenberger H. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res. 51:1991;3217-3223.
36. Panno M., Salerno M., Pezzi V., Sisci D., Maggiolini M., Mauro L. et al. Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells. J. Cancer Res. Clin. Oncol. 122:1996;745-749.
37. Pasqualini J., Nguyen B. Progesterone receptors in the fetal uterus and ovary of the guinea pig: evolution during fetal development and induction and stimulation in estradiol-primed animals. Endocrinology. 106:1980;1160-1165.
38. Pink J., Jordan V. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res. 56:1996;2321-2330.
39. Read L., Greene G., Katzenellenbogen B. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol. Endocrinol. 3:1989;295-304.
40. Saceda M., Lippman M., Chambon P., Lindsey R., Ponglikitmongkol M., Puente M. et al. Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol. Endocrinol. 2:1988;1157-1162.
41. Sharpe R., Skakkebaek N. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 341:1993;1392-1395.
42. 1 pituitary tumor cells are gene specific. Mol. Endocrinol. 6:1992;529-535.
43. Soto A., Sonnenschein C., Chung K., Fernandex M., Olea N., Olea-Serrano F. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103:1995;113-122.
44. Tasset D., Tora L., Fromental C., Scheer E., Chambon P. Distinct classes of transcriptional activating domains function by different mechanisms. Cell. 62:1990;1177-1187.
45. Tomooka Y., DiAugustine R., MacLachlan J. Proliferation of mouse uterine epithelial cell in vitro. Endocrinology. 118:1986;1011-1018.
46. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E. et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
47. Tzukerman M., Esty A., Santiso-Mere D., Danielian P., Parker M., Stein R. et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8:1994;21-30.
48. vom Saal F., Timms B., Montano M., Palanza P., Thayer K., Nagel S. et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. USA. 94:1997;2056-2061.
49. Wakeling A., Dukes M., Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:1991;3867-3873.